In vitro Antimicrobial Activity and Dose Optimization of Eravacycline and Other Tetracycline Derivatives Against Levofloxacin-Non-Susceptible and/or Trimethoprim-Sulfamethoxazole-Resistant Stenotrophomonas maltophilia

PURPOSE: To better guide clinical use, we determined the in vitro antimicrobial activity of the new drug eravacycline and other tetracycline derivatives against levofloxacin (LVFX)-non-susceptible and/or trimethoprim-sulfamethoxazole (TMP-SMZ)-resistant Stenotrophomonas maltophilia and evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jie, Zhang, Guangcun, Zhao, Qiang, Wang, Lifeng, Yang, Jiyong, Cui, Junchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497097/
https://www.ncbi.nlm.nih.gov/pubmed/37705512
http://dx.doi.org/10.2147/IDR.S425061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497097/
https://www.ncbi.nlm.nih.gov/pubmed/37705512
http://dx.doi.org/10.2147/IDR.S425061

Ejemplares similares